UROGON CYSTITIS RELIEF 4G GRANULES FOR ORAL SOLUTION
Active substance(s): SODIUM CITRATE / SODIUM CITRATE / SODIUM CITRATE
PATIENT INFORMATION LEAFLET
Urogon Cystitis Relief 4g granules for oral solution
Read all of this leaflet carefully because it contains important information for you.
This medicine is available without a prescription, for you to treat a mild illness without a
doctor’s help. Nevertheless you still need to use Cystitis Relief 4g granules for oral solution
carefully to get the best results from it.
• Keep this leaflet. You may need to read it again
• Ask your pharmacist if you need more information or advice
• You must see a doctor if your symptoms worsen or do not improve.
In this leaflet
WHAT CYSTITIS RELIEF IS AND WHAT
BEFORE YOU TAKE CYSTITIS RELIEF
HOW TO TAKE CYSTITIS RELIEF
POSSIBLE SIDE EFFECTS
HOW TO STORE CYSTITIS RELIEF
IT IS USED FOR
The name of your medicine is Urogon Cystitis Relief 4g granules for oral solution, referred to as
Cystitis Relief in this leaflet.
1. WHAT CYSTITIS RELIEF
IS AND WHAT IT IS USED FOR
Cystitis Relief contains sodium citrate which is used for the relief of the symptoms of cystitis in
Cystitis is an inflammation of the bladder, which causes painful irritation and an unpleasant
burning sensation when passing water.
Sodium citrate relieves the painful irritation caused by cystitis by making the urine less acidic.
2. BEFORE YOU TAKE CYSTITIS RELIEF
You should not take these sachets if:
You are allergic to sodium citrate or to any of the ingredients listed in section 6.
You suffer from heart disease, high blood pressure, diabetes or have a history of kidney
You are on a low salt diet.
You are pregnant or breast feeding.
You have an intolerance to some sugars.
Pregnancy and breast-feeding
Do not take Cystitis Relief if you are pregnant or breast-feeding.
Important information about some of the ingredients of Cystitis Relief
Cystitis Relief sachets contain lactose monohydrate. If you have been told by your doctor that
you have an intolerance to some sugars you should not take this medicine. They also contain
939mg sodium. To be taken into consideration if you are on a controlled sodium diet
Aspar Cystitis PIL 2.qxp
Taking other medicines
Although Cystitis Relief is not known to interact with other medicines, tell your doctor or
pharmacist if you are taking any other medicines, including those you have bought yourself.
If you miss a dose, do not take a double dose to ‘make up’ for the missed dose.
Each sachet contains granules, which should be dissolved in a glass of water to make a pleasant
cranberry flavoured drink. You should start to feel relief within a few hours.
Adult women: Take the contents of one sachet dissolved in a glass of water, three times a day for
two days. The reconstituted solution should be used immediately
Not recommended for use in men and children
If symptoms persist after the two-day course is completed, consult your doctor.
Do not repeat the treatment without medical advice.
If you miss a dose, take one as soon as you remember, but do not double up the next dose to
compensate the missed dose.
Do not take more than stated. If you have taken more than you should, seek medical advice
4. POSSIBLE SIDE EFFECTS
Side effects do not usually occur with this product. However, tell your doctor or pharmacist if you
notice any unwanted effects whilst taking this medicine.
Do not store above 25 °C. Store in the original package to protect from moisture.
Keep out of reach and sight of children.
Do not take this medicine after the expiry date shown on the sachet and carton.
6. FURTHER INFORMATION
What does each sachet contain?
Each sachet contains white granules for oral solution.
The granules contain sodium citrate 4g as the active ingredient.
The other ingredients are sucrose, colloidal anhydrous silica, saccharin sodium and cranberry
What does each pack contain?
Each pack contains 6 sachets of Cystitis Relief, sufficient for a 2 day course of treatment.
Who manufactures this medicine?
The manufacturer is: Sussex Pharmaceutical Ltd, East Grinstead, West Sussex, UK
The Marketing Authorisation holder is: Aspar Pharmaceuticals Ltd. London NW9 0EQ.
Leaflet revised: May 2008
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.